Medical management of kidney stones: AUA guideline

Margaret S Pearle, David S. Goldfarb, Dean G. Assimos, Gary Curhan, Cynthia J. Denu-Ciocca, Brian R. Matlaga, Manoj Monga, Kristina L. Penniston, Glenn M. Preminger, Thomas M T Turk, James R. White

Research output: Contribution to journalArticle

258 Citations (Scopus)

Abstract

Purpose The purpose of this guideline is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Materials and Methods The primary source of evidence for this guideline was the systematic review conducted by the Agency for Healthcare Research and Quality on recurrent nephrolithiasis in adults. To augment and broaden the body of evidence in the AHRQ report, the AUA conducted supplementary searches for articles published from 2007 through 2012 that were systematically reviewed using a methodology developed a priori. In total, these sources yielded 46 studies that were used to form evidence-based guideline statements. In the absence of sufficient evidence, additional statements were developed as Clinical Principles and Expert Opinions. Results Guideline statements were created to inform clinicians regarding the use of a screening evaluation for first-time and recurrent stone formers, the appropriate initiation of a metabolic evaluation in select patients and recommendations for the initiation and follow-up of medication and/or dietary measures in specific patients. Conclusions A variety of medications and dietary measures have been evaluated with greater or less rigor for their efficacy in reducing recurrence rates in stone formers. The guideline statements offered in this document provide a simple, evidence-based approach to identify high-risk or interested stone-forming patients for whom medical and dietary therapy based on metabolic testing and close follow-up is likely to be effective in reducing stone recurrence.

Original languageEnglish (US)
Pages (from-to)316-324
Number of pages9
JournalJournal of Urology
Volume192
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Kidney Calculi
Guidelines
Recurrence
Nephrolithiasis
Health Services Research
Expert Testimony

Keywords

  • citrate
  • hypercalciuria
  • nephrolithiasis
  • oxalate
  • urolithiasis

ASJC Scopus subject areas

  • Urology

Cite this

Pearle, M. S., Goldfarb, D. S., Assimos, D. G., Curhan, G., Denu-Ciocca, C. J., Matlaga, B. R., ... White, J. R. (2014). Medical management of kidney stones: AUA guideline. Journal of Urology, 192(2), 316-324. https://doi.org/10.1016/j.juro.2014.05.006

Medical management of kidney stones : AUA guideline. / Pearle, Margaret S; Goldfarb, David S.; Assimos, Dean G.; Curhan, Gary; Denu-Ciocca, Cynthia J.; Matlaga, Brian R.; Monga, Manoj; Penniston, Kristina L.; Preminger, Glenn M.; Turk, Thomas M T; White, James R.

In: Journal of Urology, Vol. 192, No. 2, 2014, p. 316-324.

Research output: Contribution to journalArticle

Pearle, MS, Goldfarb, DS, Assimos, DG, Curhan, G, Denu-Ciocca, CJ, Matlaga, BR, Monga, M, Penniston, KL, Preminger, GM, Turk, TMT & White, JR 2014, 'Medical management of kidney stones: AUA guideline', Journal of Urology, vol. 192, no. 2, pp. 316-324. https://doi.org/10.1016/j.juro.2014.05.006
Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR et al. Medical management of kidney stones: AUA guideline. Journal of Urology. 2014;192(2):316-324. https://doi.org/10.1016/j.juro.2014.05.006
Pearle, Margaret S ; Goldfarb, David S. ; Assimos, Dean G. ; Curhan, Gary ; Denu-Ciocca, Cynthia J. ; Matlaga, Brian R. ; Monga, Manoj ; Penniston, Kristina L. ; Preminger, Glenn M. ; Turk, Thomas M T ; White, James R. / Medical management of kidney stones : AUA guideline. In: Journal of Urology. 2014 ; Vol. 192, No. 2. pp. 316-324.
@article{43a725fb4a5b4e0ab2318b0fe6f15b01,
title = "Medical management of kidney stones: AUA guideline",
abstract = "Purpose The purpose of this guideline is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Materials and Methods The primary source of evidence for this guideline was the systematic review conducted by the Agency for Healthcare Research and Quality on recurrent nephrolithiasis in adults. To augment and broaden the body of evidence in the AHRQ report, the AUA conducted supplementary searches for articles published from 2007 through 2012 that were systematically reviewed using a methodology developed a priori. In total, these sources yielded 46 studies that were used to form evidence-based guideline statements. In the absence of sufficient evidence, additional statements were developed as Clinical Principles and Expert Opinions. Results Guideline statements were created to inform clinicians regarding the use of a screening evaluation for first-time and recurrent stone formers, the appropriate initiation of a metabolic evaluation in select patients and recommendations for the initiation and follow-up of medication and/or dietary measures in specific patients. Conclusions A variety of medications and dietary measures have been evaluated with greater or less rigor for their efficacy in reducing recurrence rates in stone formers. The guideline statements offered in this document provide a simple, evidence-based approach to identify high-risk or interested stone-forming patients for whom medical and dietary therapy based on metabolic testing and close follow-up is likely to be effective in reducing stone recurrence.",
keywords = "citrate, hypercalciuria, nephrolithiasis, oxalate, urolithiasis",
author = "Pearle, {Margaret S} and Goldfarb, {David S.} and Assimos, {Dean G.} and Gary Curhan and Denu-Ciocca, {Cynthia J.} and Matlaga, {Brian R.} and Manoj Monga and Penniston, {Kristina L.} and Preminger, {Glenn M.} and Turk, {Thomas M T} and White, {James R.}",
year = "2014",
doi = "10.1016/j.juro.2014.05.006",
language = "English (US)",
volume = "192",
pages = "316--324",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Medical management of kidney stones

T2 - AUA guideline

AU - Pearle, Margaret S

AU - Goldfarb, David S.

AU - Assimos, Dean G.

AU - Curhan, Gary

AU - Denu-Ciocca, Cynthia J.

AU - Matlaga, Brian R.

AU - Monga, Manoj

AU - Penniston, Kristina L.

AU - Preminger, Glenn M.

AU - Turk, Thomas M T

AU - White, James R.

PY - 2014

Y1 - 2014

N2 - Purpose The purpose of this guideline is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Materials and Methods The primary source of evidence for this guideline was the systematic review conducted by the Agency for Healthcare Research and Quality on recurrent nephrolithiasis in adults. To augment and broaden the body of evidence in the AHRQ report, the AUA conducted supplementary searches for articles published from 2007 through 2012 that were systematically reviewed using a methodology developed a priori. In total, these sources yielded 46 studies that were used to form evidence-based guideline statements. In the absence of sufficient evidence, additional statements were developed as Clinical Principles and Expert Opinions. Results Guideline statements were created to inform clinicians regarding the use of a screening evaluation for first-time and recurrent stone formers, the appropriate initiation of a metabolic evaluation in select patients and recommendations for the initiation and follow-up of medication and/or dietary measures in specific patients. Conclusions A variety of medications and dietary measures have been evaluated with greater or less rigor for their efficacy in reducing recurrence rates in stone formers. The guideline statements offered in this document provide a simple, evidence-based approach to identify high-risk or interested stone-forming patients for whom medical and dietary therapy based on metabolic testing and close follow-up is likely to be effective in reducing stone recurrence.

AB - Purpose The purpose of this guideline is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Materials and Methods The primary source of evidence for this guideline was the systematic review conducted by the Agency for Healthcare Research and Quality on recurrent nephrolithiasis in adults. To augment and broaden the body of evidence in the AHRQ report, the AUA conducted supplementary searches for articles published from 2007 through 2012 that were systematically reviewed using a methodology developed a priori. In total, these sources yielded 46 studies that were used to form evidence-based guideline statements. In the absence of sufficient evidence, additional statements were developed as Clinical Principles and Expert Opinions. Results Guideline statements were created to inform clinicians regarding the use of a screening evaluation for first-time and recurrent stone formers, the appropriate initiation of a metabolic evaluation in select patients and recommendations for the initiation and follow-up of medication and/or dietary measures in specific patients. Conclusions A variety of medications and dietary measures have been evaluated with greater or less rigor for their efficacy in reducing recurrence rates in stone formers. The guideline statements offered in this document provide a simple, evidence-based approach to identify high-risk or interested stone-forming patients for whom medical and dietary therapy based on metabolic testing and close follow-up is likely to be effective in reducing stone recurrence.

KW - citrate

KW - hypercalciuria

KW - nephrolithiasis

KW - oxalate

KW - urolithiasis

UR - http://www.scopus.com/inward/record.url?scp=84904254886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904254886&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.05.006

DO - 10.1016/j.juro.2014.05.006

M3 - Article

C2 - 24857648

AN - SCOPUS:84904254886

VL - 192

SP - 316

EP - 324

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -